Infections: all 6,701 studies

Page 29 of 68. Open to participants first (800), then studies with results posted, then the rest; newest registration first within each.

• Apple Respiratory StudyTerminatedNCT04912180
• Efficacy of Antibiotic Short Course for Bloodstream Infections in Acute Myeloid Leukemia Patients With Febrile NeutropeniaCompletedNCT04910698
• Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.Status unknownNCT04910438
• Consequences of a Maternal-fetal Chikungunya Virus InfectionCompletedNCT04909411Not applicable
• Clinical Assessment of Next Science Solution on Gustilo and Anderson Type II and IIIA or IIIB Tibial FracturesTerminatedNCT04906642Not applicable
• Comparison of Safety and Efficacy of de Novo EverolimusCompletedNCT04906304Not applicable
• Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected IndividualsCompletedNCT04904406Phase 4
• Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum EnterobacteriaceaeStatus unknownNCT04903886
• Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir DisproxilStatus unknownNCT04903847Phase 4
• Intravenous Antibiotic Treatment at HomeActive, not recruitingNCT04898452
• Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)CompletedNCT04896866Not applicable
• Ex Vivo Study of the Mechanism of Action of Active Ingredients on the Intestinal MicrobiotaStatus unknownNCT04895774
• Extended-infusion of Piperacillin-Tazobactam Versus Intermittent InfusionCompletedNCT04895657Phase 4
• An Open-Label Study of Apabetalone in Covid InfectionTerminatedNCT04894266Phase 2/3
• the Prevalence of Oral Manifestation in Patients With SARS-CoV2 InfectionCompletedNCT04893694
• Antibiotic Use in a Neonatal Intensive Care Unit Practicing Integrative MedicineCompletedNCT04893343
• Impact of SARS-CoV-2 (COVID-19) Infection, Treated in Ambulatory Care, on Long-term Quality of Life in a Parisian Military PopulationCompletedNCT04893070
• Helicobacter Pylori Infection Occurrence in RussiaCompletedNCT04892238
• A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)CompletedNCT04891965Phase 1
• Probiotic Modulation of Oral MicrobiotaCompletedNCT04891523Not applicable
• EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform TrialTerminatedNCT04891133Phase 2/3
• A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)CompletedNCT04888949Phase 2
• A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the NetherlandsActive, not recruitingNCT04888754
• Clinical Outcomes of Newborns Born to Pregnant Women With and Without COVID-19CompletedNCT04883801
• Comparison of Efficacy of Double Dose Oral Terbinafine Vs Itraconazole in Treatment of Dermatophyte Infections of Skin.CompletedNCT04880980Phase 3
• Clinical Study to Evaluate the Efficacy of the Dietary Supplement UROMANNOSA® in Women With Recurrent Lower Urinary Tract InfectionsSuspendedNCT04880343Not applicable
• Performance Study of SONA Saliva C-19 Rapid TestTerminatedNCT04877002Not applicable
• Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to CarbapenemsTerminatedNCT04876430Phase 2/3
• Monoclonal Antibodies in Clostridium Difficile InfectionCompletedNCT04874623Not applicable
• Effectiveness of Colchicine Among Patients With COVID-19 InfectionCompletedNCT04867226Phase 2
• Clinical Trials of Two Helichrysum Infusions in AdultsCompletedNCT04866628Not applicable
• Prognostic Factors for Descending Necrotizing Mediastinitis Development in Deep Space Neck InfectionsCompletedNCT04865003
• Evaluation of a mNGS Workflow for Infection Diagnosis Using Oxford Nanopore Sequencing.Status unknownNCT04864873Not applicable
• COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection StudyStatus unknownNCT04864548Phase 1
• Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 InfectionStatus unknownNCT04863066Phase 1
• The Effect of Umbilical Cord Clamping DistanceCompletedNCT04862403Not applicable
• Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).CompletedNCT04859023Not applicable
• Effect of Vancomycin After Catheter ReplacementStatus unknownNCT04856878Phase 4
• Efficacy of Probiotics in the Treatment of Hospitalised Patients With Novel Coronavirus InfectionCompletedNCT04854941Not applicable
• Treating Non-typhoidal Salmonella Bloodstream Infections in Children Under Five in DR Congo: a Cohort StudyCompletedNCT04850677
• Automatic Oxygen Titration in Patients After SARS-CoV-2 InfectionCompletedNCT04849598Not applicable
• Prediction of 30-Day Readmission Using Machine LearningCompletedNCT04849312
• The Factors That Affect the Infection of COVID-19CompletedNCT04848610
• Risk of COVID-19 Infection After VaccinationStatus unknownNCT04848441
• Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient TransitionTerminatedNCT04847921Phase 2/3
• Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2Status unknownNCT04846010Phase 1/2
• PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)WithdrawnNCT04842331Phase 2/3
• Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)CompletedNCT04841369Phase 3
• Efficacy and Safety of Selective Digestive Decontamination in the ICU With High Rates of Antibiotic-resistant BacteriaStatus unknownNCT04839653Not applicable
• Does Hirschsprung Disease Increase the Risk of Febrile Urinary Tract Infection in ChildrenCompletedNCT04837963
• Evaluation of Equine Antibody Treatment in Patients With COVID 19 InfectionTerminatedNCT04834908Phase 1/2
• Postoperative Antibiotics Following Primary and Secondary Breast AugmentationWithdrawnNCT04834310Phase 4
• Developing Self-care Behaviors for Urinary Tract InfectionsCompletedNCT04832581Not applicable
• Recurrent Urinary Tract Infections and the MicrobiomeTerminatedNCT04831840
• Incidence of Infection and Mortality by COVID-19 in SpecialistsCompletedNCT04828148
• Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)CompletedNCT04825600Not applicable
• Noble Meta Alloy Coated Catheters in Patients With Long Term CatheterizationStatus unknownNCT04825314Not applicable
• BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive VolunteersCompletedNCT04824638Phase 2
• Host RNA Profiles to Detect Infections in Young InfantsCompletedNCT04823026
• EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19CompletedNCT04822818Phase 3
• Parvovirus B19 Infection in Hereditary Hemolytic Anemias PatientsStatus unknownNCT04822090
• Diode Laser 940 nm in Management of Loss of Taste SensationCompletedNCT04821999Not applicable
• Oral Manifestation in Patients With SARS-CoV2 Infection.CompletedNCT04821986
• Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to CatheterCompletedNCT04821193Not applicable
• Albuvirtide in Combination With 3BNC117 in Virologically Suppressed Subjects With HIV-1 InfectionStatus unknownNCT04819347Phase 2
• Healthcare-associated Infections in Severe COVID-19 During 2020CompletedNCT04819165
• Policy Responses Against the COVID-19 Pandemic in Latin AmericaStatus unknownNCT04816318
• Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2TerminatedNCT04815018
• Electronic Consultation for AD/ADRD Residents Experiencing Infectious DiseasesWithdrawnNCT04812769Not applicable
• HIV Infection And Evolvement of Atherosclerotic PlaqueStatus unknownNCT04810364
• DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant WomenCompletedNCT04808973Phase 3
• Diagnostic Accuracy Comparison Between Telemedicine and Face-to-face Consultations in Respiratory Infection Patients.CompletedNCT04806477Not applicable
• Bacteriophage Therapy TP-102 in Diabetic Foot UlcersCompletedNCT04803708Phase 1/2
• Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary DiseaseStatus unknownNCT04803695
• Telemedicine and Face-to-face Consultations Diagnostic Accuracy Comparison in Gastrointestinal Infection PatientsStatus unknownNCT04803435Not applicable
• Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19Status unknownNCT04802382Phase 3
• Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 InfectionStatus unknownNCT04801836Phase 2
• Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant RecipientsStatus unknownNCT04801667Phase 4
• Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and StaffStatus unknownNCT04799808
• Personalized Modulation of MicrobiotaCompletedNCT04799223Not applicable
• Antimicrobial Stewardship in UTIs in Nursing HomesCompletedNCT04798365Not applicable
• Cryotherapy on Inflammatory Profile and Postoperative Pain Levels in Endodontic InfectionsCompletedNCT04798144Not applicable
• Respiratory Protection Effect of Ear-loop-type KF94 MaskCompletedNCT04794556Not applicable
• Comparison of Chlorhexidine Impregnated Dressing and Standard DressingCompletedNCT04794231Not applicable
• Microbiome Therapy in Covid-19 Primary Care SupportSuspendedNCT04793997Not applicable
• Effect of N-acetylcysteine on Oxidative Stress in COVID-19 PatientsCompletedNCT04792021Phase 3
• Conservative Treatment of Catheter - Related Injections With Gentamicine/EDTACompletedNCT04789928Phase 1
• Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult VolunteersTerminatedNCT04788459Phase 1/2
• Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household ContactsStatus unknownNCT04788407Phase 4
• COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 InfectionCompletedNCT04787510
• Bacteriophage Therapy in Patients With Prosthetic Joint InfectionsWithdrawnNCT04787250Phase 1/2
• Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE InfectionsWithdrawnNCT04785924Phase 4
• Clinical Observation of V-P Shunt and Application of "Three-step Disinfection" to Reduce Post-operative Infection RateStatus unknownNCT04785248Not applicable
• Lactamica 9: Neisseria Lactamica Inoculation in Late PregnancyCompletedNCT04784845Not applicable
• SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDYCompletedNCT04784403
• Prediction of Expected Length of Hospital Stay Using Machine LearningWithdrawnNCT04784351
• PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant TuberculosisTerminatedNCT04783727Not applicable
• Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related DiseasesStatus unknownNCT04782674
• COVID-19 Infections and Mortality in Long-term Care Facilities During the First WaveCompletedNCT04782427
• Staphylococcus Aureus Caught in Action at the Site of InfectionCompletedNCT04781569

← Infections overview